We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Stem Cells Used to Grow Neuromuscular Junctions

By LabMedica International staff writers
Posted on 12 Dec 2011
For the first time, scientists have used stem cells to grow neuromuscular junctions between human muscle cells and human spinal cord cells, the major connectors utilized by the brain to communicate and control muscles in the body.

The success at University of Central Florida (UCF; Orlando, USA) is a vital step forward in devising “human-on-a-chip” systems. More...
The systems are models that reconstruct how organs or a series of organs function in the body. Their use could fast-track medical research and drug testing, potentially delivering life-saving breakthroughs much more rapidly than the typical 10-year trajectory most drugs take now to get through animal and patient trials.

“These types of systems have to be developed if you ever want to get to a human-on-a-chip that recreates human function,” said Dr. James Hickman, a UCF bioengineer who led the groundbreaking research. “It’s taken many trials over a number of years to get this to occur using human derived stem cells."

Dr. Hickman’s study, funded through the US National Institute of Neurological Disorders and Stroke (NINDS) at the National Institutes of Health (Bethesda, MD, USA), was published in the December 2011 issue of the journal Biomaterials. Dr. Hickman is enthusiastic about the future of his research because several federal agencies recently launched an ambitious plan to jump-start research in human-on-a-chip models by making available at least USD 140 million in grant funding.

The goal of the call for action is to generate systems that include various miniature organs connected in lifelike ways to simulate human body function. This would make it possible, for instance, to evaluate drugs on human cells well before they could be tested safely and ethically on living humans. The technique could potentially be more effective than testing in lab mice and other animals currently used to screen potential drug candidates and to develop other medical treatments.

Such traditional animal testing is not only slow and expensive, but frequently leads to failures that might be overcome with better testing options. The limitations of conventional testing alternatives have dramatically slowed the emergence of new drugs, according to Dr. Hickman.

The successful UCF technique began with a collaborator, Brown University (Providence, RI, USA) Prof. Herman Vandenburgh, who gathered muscle stem cells via biopsy from adult volunteers.

Dr. Nadine Guo, a UCF research professor, conducted a series of experiments and found that numerous conditions had to come together just right to make the muscle and spinal cord cells “happy” enough to join and form working junctions. This meant searching different concentrations of cells and various timescales, among other parameters, before hitting on the suitable conditions. “Right now we rely a lot on animal systems for medical research but this is a pure human system,” Dr. Guo concluded. “This work proved that, biologically, this is workable.”

In addition to being a key requirement for any complete human-on-a-chip model, such nerve-muscle junctions might themselves prove important research tools. These junctions play key roles in amyotrophic lateral sclerosis, also known as Lou Gehrig’s disease, in spinal cord injury, and in other debilitating or life-threatening disorders. With further development, the researchers’ methods could be used to test new drugs or other treatments for these disorders even before more expansive chip-based models are developed.

Related Links:
University of Central Florida
Brown University


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Rapid Molecular Testing Device
FlashDetect Flash10
Urine Chemistry Control
Dropper Urine Chemistry Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.